These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
78 related articles for article (PubMed ID: 161138)
1. Anticataleptic action of psychostimulating drugs and serotonin in brain. Malec D; Langwiński R Acta Physiol Pol; 1979; 30(5-6):589-95. PubMed ID: 161138 [TBL] [Abstract][Full Text] [Related]
2. Central action of narcotic analgesics. V. Participation of serotonin in the mechanism of action of narcotic analgesics. Fidecka S; Langwiński R Pol J Pharmacol Pharm; 1979; 31(5):461-71. PubMed ID: 44745 [TBL] [Abstract][Full Text] [Related]
3. Influence of WA-335, a factor which blocks serotonin receptors, on neuroleptic-induced catalepsy. Maj J; Sowińska H; Baran L Arch Immunol Ther Exp (Warsz); 1976; 24(2):197-203. PubMed ID: 945050 [TBL] [Abstract][Full Text] [Related]
4. The role of serotonin in ephedrine-induced stereotypy and hypermotility. Malec D; Langwiński R; Kruszewska A Arch Immunol Ther Exp (Warsz); 1976; 24(6):829-36. PubMed ID: 138404 [TBL] [Abstract][Full Text] [Related]
5. The effect of 5-hydroxytrytamine synthesis inhibitors on neuroleptic-induced catalepsy in rats. Sarnek J; Baran L Arch Immunol Ther Exp (Warsz); 1975; 23(4):511-6. PubMed ID: 1172422 [TBL] [Abstract][Full Text] [Related]
6. Central action of narcotic analgesics. VI. Further studies on the participation of serotonin in the action of analgesics. Malec D Pol J Pharmacol Pharm; 1980; 32(5):665-72. PubMed ID: 6115369 [TBL] [Abstract][Full Text] [Related]
7. The effect of antihistamine drugs on the neuroleptic-induced catalepsy. Pawłowski L; Sidorowicz L Pol J Pharmacol Pharm; 1978; 30(5):665-73. PubMed ID: 35784 [TBL] [Abstract][Full Text] [Related]
8. Central action of narcotic analgesics. IX. Participation of serotonin in the development of tolerance to cataleptogenic effects of morphine in rats. Langwiński R; Fidecka S Pol J Pharmacol Pharm; 1981 Nov; 33(4):437-44. PubMed ID: 6460229 [TBL] [Abstract][Full Text] [Related]
9. Some central effects of kynurenic acid, 7-chlorokynurenic acid and 5,7- dichloro-kynurenic acid, glycine site antagonists. Maj J; Rogóz Z; Skuza G; Kołodziejczyk K Pol J Pharmacol; 1994; 46(3):115-24. PubMed ID: 8000442 [TBL] [Abstract][Full Text] [Related]
10. Effects of 5-HT in globus pallidus on haloperidol-induced catalepsy in rats. Wei L; Chen L Neurosci Lett; 2009 Apr; 454(1):49-52. PubMed ID: 19429052 [TBL] [Abstract][Full Text] [Related]
11. On the anticataleptic action of cyproheptadine. Maj J; Sarnek J; Klimek V; Rawlów A Pharmacol Biochem Behav; 1976 Aug; 5(2):201-5. PubMed ID: 1033567 [TBL] [Abstract][Full Text] [Related]
12. [Participation of the serotoninergic system of the brain in regulation of emotional reactivity]. Allikmets LKh; Zharkovskiĭ AM Zh Vyssh Nerv Deiat Im I P Pavlova; 1975; 25(6):1284-91. PubMed ID: 128934 [TBL] [Abstract][Full Text] [Related]
13. Studies on the mechanism of postetorphine catalepsy. Effects of clotiapine, haloperidol and rompun on postetorphine changes in concentrations of dopamine and noradrenaline in central nervous system of rats. Kania BF Acta Physiol Pol; 1980; 31(1):9-16. PubMed ID: 6103632 [TBL] [Abstract][Full Text] [Related]
14. Anticataleptic 8-OH-DPAT preferentially counteracts with haloperidol-induced Fos expression in the dorsolateral striatum and the core region of the nucleus accumbens. Ohno Y; Shimizu S; Imaki J; Ishihara S; Sofue N; Sasa M; Kawai Y Neuropharmacology; 2008 Oct; 55(5):717-23. PubMed ID: 18585397 [TBL] [Abstract][Full Text] [Related]
15. Anticataleptic effect of taurine: interaction with antiparkinsonian agents. Zebrowska-Lupina I; Porowska A Pol J Pharmacol Pharm; 1987; 39(4):329-35. PubMed ID: 2897118 [TBL] [Abstract][Full Text] [Related]
16. The effect of anti-Parkinson drugs on catalepsy induced by -methyl-p-tyrosine in rats pretreated with intraventricular 6-hydroxydopamine. Cashin CH; Sutton S Br J Pharmacol; 1973 Mar; 47(3):658P-659P. PubMed ID: 4738385 [No Abstract] [Full Text] [Related]
17. Central action of narcotic analgesics. I. Catalepsy and stereotypy in rats and narcotic analgesics. Malec D; Fidecka S; Langwiński R Pol J Pharmacol Pharm; 1977; 29(3):177-93. PubMed ID: 560683 [TBL] [Abstract][Full Text] [Related]
18. An inhibitory role for brain serotonin-containing systems in the locomotor effects of d-amphetamine. Hollister AS; Breese GR; Kuhn CM; Cooper BR; Schanberg SM J Pharmacol Exp Ther; 1976 Jul; 198(1):12-22. PubMed ID: 132524 [TBL] [Abstract][Full Text] [Related]
19. Effects of an atypical barbiturate (valofan) on spontaneous and stimulated locomotor activity and on brain serotonin metabolism in mice. Traversa U; Puppini P; Florio C; Vertua R Farmaco Sci; 1987 Oct; 42(10):755-66. PubMed ID: 2449358 [TBL] [Abstract][Full Text] [Related]
20. Central action of narcotic analgesics. VII. The role of serotonin in the development of morphine tolerance in the locomotor activity test in mice and rats. Langwiński R; Fidecka S Pol J Pharmacol Pharm; 1981; 33(2):193-202. PubMed ID: 6458804 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]